Curing cancer with Cannabidiol?
- CANNABIS OIL, NEWS
- April 24, 2013
A recent study published in the Journal of Ethnopharmacology has shed light on the promising potential of medicinal plants in managing diabetes. Researchers conducted a comprehensive review of traditional medicinal plants used in various cultures to treat diabetes and its complications. The study identified several plant species with significant antidiabetic properties, including the ability to
READ MOREA new advocacy group, CannCare, has been established in the UK to protect medical cannabis patients from discrimination. Despite medicinal cannabis being legal for over six years, patients prescribed cannabis-based products for medicinal use (CBPM) often face stigma and harassment due to misinformation about its legality. CannCare aims to address these issues through legal advocacy,
READ MOREA groundbreaking study published in Experimental & Molecular Medicine has revealed that cannabidiol (CBD) can enhance exercise endurance by altering the gut microbiome. The research, conducted on mice, demonstrated that CBD improved muscle endurance, mitochondrial function, and oxidative capacity. However, these effects were negated when antibiotics were introduced, underscoring the critical role of gut bacteria
READ MOREFor those seeking the potential benefits of cannabidiol (CBD) without the psychoactive effects of THC, THC-free CBD oils present an appealing option. These products come in two forms: CBD isolate, which contains only pure CBD, and broad-spectrum CBD, which includes other cannabinoids and plant compounds but excludes THC. A recent Healthline article highlights some of
READ MOREA Glasgow mother is urgently campaigning for access to a cannabis-based medication she believes could save her young daughter from life-threatening seizures. The child suffers from a severe form of epilepsy, experiencing frequent and debilitating seizures that have not responded to conventional treatments. The mother argues that cannabis oil, which has shown promise in managing
READ MOREThe U.S. Drug Enforcement Administration (DEA) has postponed its cannabis rescheduling hearings, originally slated for January 21, 2025, following legal challenges from pro-reform participants. The delay, expected to last at least three months, stems from allegations of improper communications and biased witness selections by the DEA. Advocates argue these actions reveal the agency’s opposition to
READ MORE